169 related articles for article (PubMed ID: 34931867)
21. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
Wei GY; Hu M; Zhao L; Guo WS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
[TBL] [Abstract][Full Text] [Related]
22. MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
Zhou X; Zhu HQ; Ma CQ; Li HG; Liu FF; Chang H; Lu J
Biomed Pharmacother; 2016 Apr; 79():315-20. PubMed ID: 27044843
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-203 Increases Cell Radiosensitivity via Directly Targeting Bmi-1 in Hepatocellular Carcinoma.
Shao Y; Zhang D; Li X; Yang J; Chen L; Ning Z; Xu Y; Deng G; Tao M; Zhu Y; Jiang J
Mol Pharm; 2018 Aug; 15(8):3205-3215. PubMed ID: 29906128
[TBL] [Abstract][Full Text] [Related]
25. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.
E Abdelaziz H; El-Guendy N; Radwan EM; Sharawi SK; El-Houseini ME; Abdel-Wahab AA
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4125-4135. PubMed ID: 36579994
[TBL] [Abstract][Full Text] [Related]
26. Elevated hepatic MDR3/ABCB4 is directly mediated by MiR-378a-5p in human obstructive cholestasis.
Song CW; Qiu W; Zhou XQ; Feng XC; Chen WS
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2539-2547. PubMed ID: 30964181
[TBL] [Abstract][Full Text] [Related]
27. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1.
Shang Y; Zhang Z; Liu Z; Feng B; Ren G; Li K; Zhou L; Sun Y; Li M; Zhou J; An Y; Wu K; Nie Y; Fan D
Oncogene; 2014 Jun; 33(25):3267-76. PubMed ID: 23893241
[TBL] [Abstract][Full Text] [Related]
28. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
29. Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion.
Leung WK; He M; Chan AW; Law PT; Wong N
Cancer Lett; 2015 Jun; 362(1):97-105. PubMed ID: 25813403
[TBL] [Abstract][Full Text] [Related]
30. Circular RNA circFBXO11 modulates hepatocellular carcinoma progress and oxaliplatin resistance through miR-605/FOXO3/ABCB1 axis.
Li J; Qin X; Wu R; Wan L; Zhang L; Liu R
J Cell Mol Med; 2020 May; 24(9):5152-5161. PubMed ID: 32222024
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-141-regulated KLK10 and TNFSF-15 gene expression in hepatoblastoma cells as a novel mechanism in liver carcinogenesis.
Awad AM; Dabous E; Alalem M; Alalem N; Nasr ME; Elawdan KA; Nasr GM; Said W; El Khashab K; Basiouny MS; Guirgis AA; Khalil H
Sci Rep; 2024 Jun; 14(1):13492. PubMed ID: 38866875
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
[TBL] [Abstract][Full Text] [Related]
33. MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.
Zhang Y; Li T; Guo P; Kang J; Wei Q; Jia X; Zhao W; Huai W; Qiu Y; Sun L; Han L
Sci Rep; 2014 Sep; 4():6248. PubMed ID: 25175916
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells.
Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X
Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953
[TBL] [Abstract][Full Text] [Related]
35. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
36. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma.
Karimkhanloo H; Mohammadi-Yeganeh S; Hadavi R; Koochaki A; Paryan M
Mol Biol Rep; 2020 Oct; 47(10):7429-7437. PubMed ID: 32901357
[TBL] [Abstract][Full Text] [Related]
37. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
[TBL] [Abstract][Full Text] [Related]
38. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway.
Tan A; Li Q; Chen L
Arch Biochem Biophys; 2019 Jan; 661():196-202. PubMed ID: 30468709
[TBL] [Abstract][Full Text] [Related]
39. miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma.
Shyu YC; Lee TL; Lu MJ; Chen JR; Chien RN; Chen HY; Lin JF; Tsou AP; Chen YH; Hsieh CW; Huang TS
J Transl Med; 2016 Jul; 14(1):200. PubMed ID: 27370270
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
Long J; Jiang C; Liu B; Fang S; Kuang M
Tumour Biol; 2016 May; 37(5):5821-8. PubMed ID: 26581909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
